The utility of the 21-gene Oncotype DX Breast Recurrence Score® assay in node-negative breast cancer patients – the final analysis of the Polish real life survey PONDx

Saved in:
Bibliographic Details
Main Authors: Michał Jarząb, Maria Litwiniuk, Paige Innis, Aleksandra Łacko, Gesine Enderle, Bogumiła Czartoryska-Arłukowicz, Małgorzata Talerczyk, Joanna Streb, Piotr Wysocki, Grażyna Suchodolska, Bartosz Szymanowski, Renata Duchnowska
Format: Article
Language:English
Published: Termedia Publishing House 2024-10-01
Series:Contemporary Oncology
Subjects:
Online Access:https://www.termedia.pl/The-utility-of-the-21-gene-Oncotype-DX-Breast-Recurrence-Score-assay-in-node-negative-breast-cancer-patients-the-final-analysis-of-the-Polish-real-life-survey-PONDx,3,55001,1,1.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584800572014592
author Michał Jarząb
Maria Litwiniuk
Paige Innis
Aleksandra Łacko
Gesine Enderle
Bogumiła Czartoryska-Arłukowicz
Małgorzata Talerczyk
Joanna Streb
Piotr Wysocki
Grażyna Suchodolska
Bartosz Szymanowski
Renata Duchnowska
author_facet Michał Jarząb
Maria Litwiniuk
Paige Innis
Aleksandra Łacko
Gesine Enderle
Bogumiła Czartoryska-Arłukowicz
Małgorzata Talerczyk
Joanna Streb
Piotr Wysocki
Grażyna Suchodolska
Bartosz Szymanowski
Renata Duchnowska
author_sort Michał Jarząb
collection DOAJ
format Article
id doaj-art-866bc6cc12b84a6399a9ec5aa6903e68
institution Kabale University
issn 1428-2526
1897-4309
language English
publishDate 2024-10-01
publisher Termedia Publishing House
record_format Article
series Contemporary Oncology
spelling doaj-art-866bc6cc12b84a6399a9ec5aa6903e682025-01-27T11:19:21ZengTermedia Publishing HouseContemporary Oncology1428-25261897-43092024-10-0128324525210.5114/wo.2024.14422255001The utility of the 21-gene Oncotype DX Breast Recurrence Score® assay in node-negative breast cancer patients – the final analysis of the Polish real life survey PONDxMichał JarząbMaria LitwiniukPaige InnisAleksandra ŁackoGesine EnderleBogumiła Czartoryska-ArłukowiczMałgorzata TalerczykJoanna StrebPiotr WysockiGrażyna SuchodolskaBartosz SzymanowskiRenata Duchnowskahttps://www.termedia.pl/The-utility-of-the-21-gene-Oncotype-DX-Breast-Recurrence-Score-assay-in-node-negative-breast-cancer-patients-the-final-analysis-of-the-Polish-real-life-survey-PONDx,3,55001,1,1.htmlbreast cancer oncotype dx breast recurrence score® adjuvant chemotherapy real life study
spellingShingle Michał Jarząb
Maria Litwiniuk
Paige Innis
Aleksandra Łacko
Gesine Enderle
Bogumiła Czartoryska-Arłukowicz
Małgorzata Talerczyk
Joanna Streb
Piotr Wysocki
Grażyna Suchodolska
Bartosz Szymanowski
Renata Duchnowska
The utility of the 21-gene Oncotype DX Breast Recurrence Score® assay in node-negative breast cancer patients – the final analysis of the Polish real life survey PONDx
Contemporary Oncology
breast cancer
oncotype dx breast recurrence score®
adjuvant chemotherapy
real life study
title The utility of the 21-gene Oncotype DX Breast Recurrence Score® assay in node-negative breast cancer patients – the final analysis of the Polish real life survey PONDx
title_full The utility of the 21-gene Oncotype DX Breast Recurrence Score® assay in node-negative breast cancer patients – the final analysis of the Polish real life survey PONDx
title_fullStr The utility of the 21-gene Oncotype DX Breast Recurrence Score® assay in node-negative breast cancer patients – the final analysis of the Polish real life survey PONDx
title_full_unstemmed The utility of the 21-gene Oncotype DX Breast Recurrence Score® assay in node-negative breast cancer patients – the final analysis of the Polish real life survey PONDx
title_short The utility of the 21-gene Oncotype DX Breast Recurrence Score® assay in node-negative breast cancer patients – the final analysis of the Polish real life survey PONDx
title_sort utility of the 21 gene oncotype dx breast recurrence score r assay in node negative breast cancer patients the final analysis of the polish real life survey pondx
topic breast cancer
oncotype dx breast recurrence score®
adjuvant chemotherapy
real life study
url https://www.termedia.pl/The-utility-of-the-21-gene-Oncotype-DX-Breast-Recurrence-Score-assay-in-node-negative-breast-cancer-patients-the-final-analysis-of-the-Polish-real-life-survey-PONDx,3,55001,1,1.html
work_keys_str_mv AT michałjarzab theutilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT marialitwiniuk theutilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT paigeinnis theutilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT aleksandrałacko theutilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT gesineenderle theutilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT bogumiłaczartoryskaarłukowicz theutilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT małgorzatatalerczyk theutilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT joannastreb theutilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT piotrwysocki theutilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT grazynasuchodolska theutilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT bartoszszymanowski theutilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT renataduchnowska theutilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT michałjarzab utilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT marialitwiniuk utilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT paigeinnis utilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT aleksandrałacko utilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT gesineenderle utilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT bogumiłaczartoryskaarłukowicz utilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT małgorzatatalerczyk utilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT joannastreb utilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT piotrwysocki utilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT grazynasuchodolska utilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT bartoszszymanowski utilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx
AT renataduchnowska utilityofthe21geneoncotypedxbreastrecurrencescoreassayinnodenegativebreastcancerpatientsthefinalanalysisofthepolishreallifesurveypondx